From the November 2021 issue of HealthCare Business News magazine
In September, Canon Medical Systems announced it had teamed up with the National Cancer Center Japan and EAST Hospital in Kashiwa to further research on the use of photon-counting CT (PCCT).
PCCT is an advanced diagnostic imaging technique designed to identify multiple material components by measuring X-ray photons at different energy levels. Doing so enables it to enhance image resolution and quality, while reducing dose exposure compared to conventional CT.
Canon and the center’s Exploratory Oncology Research & Clinical Trial Center (NCC-EPOC) will use the quantitative capabilities of photon counting CT to assess treatment effects from chemotherapeutic agents on malignant tumors. They will also analyze different tissue characteristics for clinical insights on a wide range of medical fields.
Ad Statistics
Times Displayed: 2548
Times Visited: 12 Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.
"We hope our PCCT system will bring new clinical benefits to patients all over the world. These benefits are based on the identification of multiple material components, the higher resolution images, and lower exposure doses," Tomokazu Harada, a senior manager of CT marketing and promotion department for Canon Medical Systems, told HCB News.
Global CT market to hit $6.14 billion by 2025
The CT market is on its way to being worth $6.14 billion by 2025, with demand driven by providers worldwide looking to upgrade from low-end CT to mid- and high-end CT scanners, according to a September report from Frost & Sullivan.
Currently valued at $4.16 billion, the consulting firm predicts opportunities in the market for traditional and mobile CT, cardiac scanning and AI-powered imaging for cancer diagnostics. It is already witnessing an expansion in clinical applications and new technological innovations being developed, and puts the compound annual growth rate for the rise at 8.1%.
"Due to a large existing installed base of scanners with fewer than 16 slices in emerging and developing economies purchased between 2012 and 2014, pent-up demand for CT replacements propels the growth of higher-slice CT. During the COVID-19 pandemic, mobile CT has potentially influenced purchase and usage to assess lung infection. In the stationary CT, 64 slice CT scanners have a better penetration rate," Poornima Srinivasan, Frost & Sullivan consultant for healthcare & lifesciences, told HCB News.
Driving the trend for these high-end technology scanners are cardiac, neurology and liver imaging, with university and academic centers and public hospitals in North America, Western Europe, and Japan expected to propel revenue for this segment. Demand for 16- to 64-slice scanners are also expected to grow moderately at diagnostic imaging centers in developing regions of LATAM, India and China.
